Fulton Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,333
| Closed | -$206K | – | 511 |
|
|
2021
Q4 | $206K | Buy |
+2,333
| New | +$206K | 0.01% | 515 |
|
|
2021
Q3 | – | Sell |
-4,170
| Closed | -$348K | – | 525 |
|
|
2021
Q2 | $348K | Buy |
4,170
+331
| +9% | +$27.6K | 0.02% | 367 |
|
|
2021
Q1 | $290K | Buy |
3,839
+408
| +12% | +$30.8K | 0.01% | 390 |
|
|
2020
Q4 | $301K | Buy |
3,431
+263
| +8% | +$23.1K | 0.02% | 350 |
|
|
2020
Q3 | $241K | Buy |
3,168
+521
| +20% | +$39.6K | 0.01% | 375 |
|
|
2020
Q2 | $326K | Buy |
2,647
+218
| +9% | +$26.8K | 0.02% | 301 |
|
|
2020
Q1 | $205K | Buy |
+2,429
| New | +$205K | 0.02% | 347 |
|